GL1X · GenesisL1 explorer

Research workbench

Crystal structure of nadr in complex with 4-hydroxyphenylacetate

Analyse Crystal structure of nadr in complex with 4-hydroxyphenylacetate in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AIP
Type
protein
Length
273 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcriptional regulator, marr family
UniProt
Q7DD70
Ligands
4HP
Pockets
4 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 73% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATranscriptional regulator, marr familyprotein14168% helix, 7% strandQ7DD70
BTranscriptional regulator, marr familyprotein13277% helix, 8% strandQ7DD70

Ligands and binding sites

  • 4HP · 4-hydroxyphenylacetate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1750.630.91184HP
21970.460.7529empty
31080.360.7421empty
4640.290.7415empty

Interfaces

1 interface between chains.

  • A–B · 2630 Ų buried · 25 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 modified (engineered).

Compared structures

  • 5AIP · Crystal structure of NadR in complex with 4-hydroxyphenylacetate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.